About Achieva
Current Location:Home>About us

 Achieva Medical (Shanghai) Co., Ltd. was founded in San Diego, CA, United States in 2003. In Mar. 2006, Achieva Medical set up its research and production base in Zhangjiang High Tech Park, Shanghai, China. In 2016, the Suzhou company was established while its brand new 15,000 m2 R&D and production site has been put into use in the China-Singapore Suzhou Industrial Park. 

 


Achieva Medical, a high-tech company which has its own brands and world-leading intellectual property rights, is committed to developing, manufacturing and marketing the cerebral vascular interventional products. We are dedicated in becoming a Chinese comprehensive cerebral interventional device provider.


Achieva's Management Team is composed of seasoned executives and technical experts from medical device industry. The management team members hold Ph.D degrees or master degrees from prestigious universities such as MIT, Stanford University, UC Berkeley and others. Up until now, the company had received all sort of recognitions and honors including 16 invention and utility model patents, certificate of ‘High-Tech Enterprise’, identification of High and New Technology Achievement, and Innovation and entrepreneurship competition winning enterprise award etc.


Jasper neurovascular embolization detachable coil is Achieva’s first generation intracranial aneurysm coil product. After six years of research and development efforts, Achieva has successfully developed a novel joining technique of applying unique polymer material which enables reliable and consistent detachment of the embolic coil.  In 2009, upon completing a series of test which included ISO biocompatibility test, chemical test and statistical-meaningful clinical trials, Jasper coil was certified by CFDA and Achieva had, therefore, become the first Chinese company that produces and markets intracranial treatment coil products.  In the same year, Jasper coil had received the certification of ISO13485 and CE mark as well. 


In Mar. 2016, Presgo® mechanical detachable coil, Achieva’s second generation coil product, received PMDA approval to market in Japan. Presgo® mechanical detachable coil has, therefore, become the first high-level neurovascular interventional device solely developed and made by a Chinese enterprise that ever entered the Japanese market. In 2007Achieva Medical has consecutively received CFDA approval on Presgo® micro guidewire and Presgo® micro catheter. The company has gradually been speeding up its pace in developing a complete set of interventional products.


"To build an innovation and R&D platform for doctors, to take social responsibilities for patients", is Achieva's philosophy. Under this guidance, Achieva actively communicates with major clinical centers in China for product development needs, and involves in several types of study activities and research programs.  As the company is growing, in the early years, Achieva participated the "爱心长征" volunteer program, organized by Society of China Neuro Surgeon. In this program, Achieva offered free Jasper coils for poor patients from rural western region of China, to help them get access to intracranial aneurysms embolization treatment. In addition, Achieva initiated an "Achieva Care" Plan by providing free coils to assist patients who could not afford interventional therapy due to the shortage of a small portion of funds.


In 2017, Achieva founded “Yumiao”fund (“玉苗”基金) in Yushu,which will aid those academic excellent but financial difficult students to change their fate with their own hardwork. Meanwhile, we organized volunteer free clinic which brought urgently needed drugs and medical support to local Tibetans who live in remote areas.


Achieva Medical is deeply rooted in China. Through close cooperation with clinical centers, we shall benefit more Chinese patients by developing and producing products that better meet clinical needs. 


        Together, We Achieve A Miracle